[{"id":"d78d9e2f-3c77-49ca-aca9-de0c64463134","acronym":"","url":"https://clinicaltrials.gov/study/NCT03864042","created_at":"2021-01-18T19:03:40.345Z","updated_at":"2024-07-02T16:35:46.191Z","phase":"Phase 1","brief_title":"Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors","source_id_and_acronym":"NCT03864042","lead_sponsor":"Pfizer","biomarkers":" BRAF","pipe":" | ","alterations":" BRAF V600E • BRAF V600K","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF V600E • BRAF V600K"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Mektovi (binimetinib) • Braftovi (encorafenib) • modafinil • omeprazole"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 56","initiation":"Initiation: 01/02/2018","start_date":" 01/02/2018","primary_txt":" Primary completion: 07/11/2022","primary_completion_date":" 07/11/2022","study_txt":" Completion: 06/30/2023","study_completion_date":" 06/30/2023","last_update_posted":"2023-06-08"}]